Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Revenue

In the year 2025, Jiangsu Aidea Pharmaceutical Group had annual revenue of 719.17M CNY with 72.13% growth. Jiangsu Aidea Pharmaceutical Group had revenue of 166.77M in the quarter ending December 31, 2025, with 40.23% growth.

• Revenue: 719.17M
• Revenue Growth: +72.13%
• P/S Ratio: 10.39
• Revenue / Employee: 1.02M
• Employees: 735
• Market Cap: 7.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	719.17M	301.37M	72.13%
Dec 31, 2024	417.80M	6.44M	1.57%
Dec 31, 2023	411.36M	167.14M	68.44%
Dec 31, 2022	244.22M	-11.49M	-4.49%
Dec 31, 2021	255.71M	-33.35M	-11.54%